CNBX Pharmaceuticals Inc.
CNBX
$0.00
$0.00-20.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.10K | 13.60K | 45.70K | 17.30K | 26.40K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.30K | 5.00K | 5.00K | 5.00K | 5.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.40K | 18.60K | 50.70K | 22.30K | 31.40K |
|
|
|||||
| Total Current Assets | 18.40K | 18.60K | 50.70K | 22.30K | 31.40K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 18.40K | 18.60K | 50.70K | 22.30K | 31.40K |
|
|
|||||
| Total Accounts Payable | 49.30K | 41.20K | 62.90K | 52.00K | 40.80K |
| Total Accrued Expenses | 1.04M | -- | -- | -- | 932.80K |
| Short-term Debt | 1.20M | 1.34M | 1.40M | 1.33M | 1.30M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 223.60K | 1.17M | 1.16M | 1.16M | 242.60K |
| Total Other Current Liabilities | 223.60K | 1.17M | 1.16M | 1.16M | 242.60K |
| Total Current Liabilities | 2.51M | 2.56M | 2.62M | 2.54M | 2.51M |
|
|
|||||
| Total Current Liabilities | 2.51M | 2.56M | 2.62M | 2.54M | 2.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.20M | 1.34M | 1.40M | 1.33M | 1.30M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.51M | 2.56M | 2.62M | 2.54M | 2.51M |
|
|
|||||
| Common Stock & APIC | 22.77M | 22.58M | 22.49M | 22.47M | 22.47M |
| Retained Earnings | -25.27M | -25.12M | -25.06M | -24.99M | -24.95M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.50M | -2.54M | -2.57M | -2.51M | -2.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.50M | -2.54M | -2.57M | -2.51M | -2.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.50M | -2.54M | -2.57M | -2.51M | -2.48M |
|
|
|||||